[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 6, Issue 1 (6-2022) ::
CRMS 2022, 6(1): 15-24 Back to browse issues page
Evaluation of the Pattern of Antinuclear Antibodies (ANA) Profile among Patients Suffering from Three Major Rheumatic Diseases
M Fereidouni * , E Atabati , S Khojasteh-Kaffash , A Fanoodi , A Bahrami , M R Mogharrabi , M Zardast
Cellular and Molecular Research Center, Birjand University of Medical Sciences, Birjand, Iran , dr.m.fereidouni@gmail.com
Abstract:   (788 Views)
Background and Objective: Autoimmune diseases (AIDs) are characterized by tissue destruction or organ dysfunction by the body’s own immune system. The anti-nuclear antibodies (ANA) test is a helpful test for diagnosing and classifying ANA-associated rheumatic diseases (AARDs). This study aimed to evaluate the frequency and profile of autoantibodies among patients suffering from systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and Sjogren's syndrome (SS).
Methods: This cross-sectional study was performed on patients who referred to the Rheumatology Clinic of Birjand University of Medical Sciences. Demographic data and information about risk factors were collected by a questionnaire. In confirmed cases, the presence of autoantibodies was detected by Fluorescent method (FANA). In all positive patients, ANA profiles were identified.
Findings: Totally, 138 patients were included in this study. Prevalence of the three main diseases including SLE, RA, and SS was 45.5%, 39.0%, and 15.4%, respectively and being overweight was the most common risk factor. The rate of positive FANA test was 71.4%, 43.8%, and 78.9% in SLE, RA, and SS, respectively. In the case of autoantibodies, Ro-52 autoantibody had the highest prevalence. The most common co-incidence of autoantibodies was for DFS70 with PM-Scl100.
Conclusion: The results of this study showed that the mean titers of ANAs were higher in SS patients. The Ro-52 autoantibody was the most commonly detected autoantibody. There was no specific profile of autoantibodies for none of the studied diseases. Further studies are needed to evaluate the correlation between the presence of particular autoantibodies with the prognosis of the patients.
Article number: 3
Keywords: Antinuclear Autoantibodies (ANA), Autoimmune Diseases (AIDs), Rheumatoid Arthritis (RA), Sjogren's Syndrome (SS), Systemic Lupus Erythematosus (SLE)
Full-Text [PDF 582 kb]   (587 Downloads)    
Type of Study: Original Article | Subject: داخلی ( روماتولوژی )
Received: 2022/01/14 | Accepted: 2022/05/30 | Published: 2022/07/20
Send email to the article author

Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fereidouni M, Atabati E, Khojasteh-Kaffash S, Fanoodi A, Bahrami A, Mogharrabi M R et al . Evaluation of the Pattern of Antinuclear Antibodies (ANA) Profile among Patients Suffering from Three Major Rheumatic Diseases. CRMS 2022; 6 (1) : 3
URL: http://crms.mubabol.ac.ir/article-1-120-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6, Issue 1 (6-2022) Back to browse issues page
Current Research in Medical Sciences
Persian site map - English site map - Created in 0.04 seconds with 36 queries by YEKTAWEB 4624